Episode Details

Back to Episodes

“GOAL 3 has a US$2.15M gap for 2027 to further validate and scale IMPALA” by Channelijne (Chan) Hulshof🔹, Niek Versteegde, founder GOAL 3, Jelle Schuitemaker - GOAL 3

Published 18 hours ago
Description

TL;DR

  • The GOAL 3 Foundation helps hospitals in sub-Saharan Africa implement IMPALA, a system that unburdens health workers and enables them to monitor critically ill children and newborns and respond early to deteriorations and improvement.
  • Current measured mortality effects were put at 42% reduction for children, and 26% for newborns by Rethink Priorities. After discounting these by 72% for internal and external validity, it models 12% and 7%, and estimates IMPALA at about 76x (children) and 28x (newborns) as cost-effective as cash transfers, against GiveWell's bar of 6x.
  • In 2027 and 2028 we want to expand our installed base from ~70 hospitals to about 400 through a mix of hospital and government payments, programme funding and philanthropy. The Foundation's fundraising target for this period is US5.3 million dollars, including an independent evaluation of IMPALA in routine care. Nothing is contracted yet, so our gap is about US2.15 million dollars for 2027 and US3.15 million dollars for 2028.
  • We expect funding now to be unusually catalytic: it strengthens the evidence and brings costs down through scale, which makes it easier for governments, NGOs and large funders to take IMPALA on.

Where we are

IMPALA is continuous vital-signs monitoring for [...]

---

Outline:

(00:20) TL;DR

(01:49) Where we are

(05:20) Where we want to be by the end of 2028

(06:23) What additional funding would buy

(06:48) 1) More wards

(07:32) 2) An independent evaluation in routine care

(08:15) 3) Larger amounts

(09:16) Why now

(11:06) What could go wrong

(12:31) How to give, and getting in touch

(13:38) How this post was written

---

First published:
November 20th, 2026

Source:
https://forum.effectivealtruism.org/posts/bAG98RfWeuq4wK5ph/goal-3-has-a-ususd2-15m-gap-for-2027-to-further-validate-and

---

Narrated by TYPE III AUDIO.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us